Immunoglobulin deposition in atherosclerotic aortocoronary saphenous vein grafts. 1990

M Fitzmaurice, and N B Ratliff
Department of Pathology, Cleveland Clinic Foundation, OH 44195-5138.

Aortocoronary saphenous vein grafts develop a rapidly progressive atherosclerosis that is diffuse, concentric, and histologically distinct from that in native coronary arteries. To explore a possible role of immunologic injury in this form of atherosclerosis, frozen sections of saphenous vein grafts and normal saphenous vein controls were examined for deposits of immunoglobulins, C3, and fibrinogen by direct immunofluorescence. Immunoglobulins were found in 19 of 24 grafts, all with diffuse concentric intimal fibroplasia or atherosclerosis. No immunoglobulins were found in 5 grafts with focal eccentric atherosclerosis or organized thrombi or in the five controls. C3 and fibrinogen were also found in the majority of grafts and controls. Immunoglobulins were distributed concentrically throughout the intima or associated with atheromatous debris. The amount of immunoglobulin correlated with the amount of atheromatous debris.

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D005260 Female Females
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D005487 Foam Cells Lipid-laden macrophages originating from monocytes or from smooth muscle cells. Cell, Foam,Cells, Foam,Foam Cell
D006083 Graft Occlusion, Vascular Obstruction of flow in biological or prosthetic vascular grafts. Graft Restenosis, Vascular,Vascular Graft Occlusion,Vascular Graft Restenosis,Graft Restenoses, Vascular,Occlusion, Vascular Graft,Restenosis, Vascular Graft
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Fitzmaurice, and N B Ratliff
January 1988, Cardiovascular clinics,
M Fitzmaurice, and N B Ratliff
January 1977, Revista espanola de cardiologia,
M Fitzmaurice, and N B Ratliff
January 1990, The Journal of cardiovascular surgery,
M Fitzmaurice, and N B Ratliff
October 1974, The American journal of cardiology,
M Fitzmaurice, and N B Ratliff
January 1988, The American journal of cardiology,
M Fitzmaurice, and N B Ratliff
August 2013, Histochemistry and cell biology,
M Fitzmaurice, and N B Ratliff
May 2000, Heart, lung & circulation,
M Fitzmaurice, and N B Ratliff
February 2001, The Annals of thoracic surgery,
M Fitzmaurice, and N B Ratliff
June 1971, Surgery,
M Fitzmaurice, and N B Ratliff
September 1979, Cardiovascular diseases,
Copied contents to your clipboard!